Search results for "coronavirus 2"

showing 10 items of 549 documents

High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households

2020

AbstractIn a survey of household cats and dogs of laboratory-confirmed COVID-19 patients, we found a high seroprevalence of SARS-CoV-2 antibodies, ranging from 21% to 53%, depending on the positivity criteria chosen. Seropositivity was significantly greater among pets from COVID-19+ households compared to those with owners of unknown status. Our results highlight the potential role of pets in the spread of the epidemic.

0303 health sciencesHigh prevalenceCATSbiologyCoronavirus disease 2019 (COVID-19)040301 veterinary sciencesbusiness.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)04 agricultural and veterinary sciences3. Good health0403 veterinary science03 medical and health sciencesEnvironmental healthbiology.proteinMedicineSeroprevalenceAntibodybusiness030304 developmental biology
researchProduct

Impact of COVID-19 on the self-reported physical activity of people with complete thoracic spinal cord injury full-time manual wheelchair users

2021

Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Activitat física; Lesió medul·lar Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Actividad física; Lesión de la médula espinal Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Physical activity; Spinal cord injury Context The emergence of COVID-19 caused a new public health crisis, leading to major changes in daily life routines, often including physical activity (PA) levels. The main goal of this study was to analyze the differences in self-reported physical activity of people with complete spinal cord injuries between the time prior to the COVID-19 lockdown and the lockdown period itself. Methods A sample of 20 participants with complete thoracic spi…

030506 rehabilitationmedicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Clinical NeurologyPhysical activityManual wheelchair:terapéutica::terapéutica::modalidades de fisioterapia::terapéutica::tratamiento por actividad física [TÉCNICAS Y EQUIPOS ANALÍTICOS DIAGNÓSTICOS Y TERAPÉUTICOS]03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitation:Therapeutics::Therapeutics::Physical Therapy Modalities::Therapeutics::Exercise Therapy [ANALYTICAL DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT]:virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus [ENFERMEDADES]Pandèmia de COVID-19 2020-HumansMedicine:enfermedades del sistema nervioso::enfermedades del sistema nervioso central::enfermedades de la médula espinal::traumatismos de la médula espinal [ENFERMEDADES]ExercisePandemicsSpinal cord injurySpinal Cord Injuriesbusiness.industryPublic healthCOVID-19:Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [DISEASES]medicine.disease:Nervous System Diseases::Central Nervous System Diseases::Spinal Cord Diseases::Spinal Cord Injuries [DISEASES]WheelchairsCommunicable Disease ControlSelf ReportNeurology (clinical)0305 other medical sciencebusinessMedul·la espinal - Malalties - Exercici terapèutic030217 neurology & neurosurgeryThoracic spinal cord injuryThe Journal of Spinal Cord Medicine
researchProduct

COVID-19 Infection Process in Italy and Spain: Are the Data Talking?

2020

Background: COVID-19 has spread successfully worldwide in a matter of weeks. After the example of China, all the affected countries are taking hard-confinement measures to control the infection and to gain some time to diminish the big amount of cases that arrive to hospital. Although the measures in China reduced the percentages of new cases, this is not seen in other countries that have taken similar measures, such as Italy and Spain. Now we are in the middle of a battle trying to prevent the healthcare system from collapsing while it effectively responds to the needs of patients who are infected and require hospitalization. Methods: Using China as a mirror of what could happen in our cou…

2019-20 coronavirus outbreakARIMA methodGeographyContagion patternCoronavirus disease 2019 (COVID-19)ItalySpainSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)COVID-19Economía AplicadaChinaSocioeconomicsForecasting
researchProduct

Prevalence of SARS-CoV-2-IgG Antibodies in Children with CKD or Immunosuppression

2021

Coronavirus disease 2019 (COVID-19) rapidly spread from China as a pandemic, with Italy one of the most affected countries worldwide. Unlike adults, children have a milder presentation of COVID-19, even when affected by CKD or on immunosuppressive therapy for glomerulopathies and kidney

2019-20 coronavirus outbreakAdolescentCoronavirus disease 2019 (COVID-19)Epidemiologymedicine.medical_treatmentSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Antibodies ViralCritical Care and Intensive Care MedicineIdiopathic Nephrotic SyndromeImmunoglobulin GPandemicPrevalenceResearch LetterHumansMedicineRenal Insufficiency ChronicChildImmunosuppression TherapyTransplantationbiologySARS-CoV-2business.industryCOVID-19InfantImmunosuppressionNephrologyChild PreschoolImmunoglobulin GImmunologybiology.proteinAntibodybusinessClinical Journal of the American Society of Nephrology
researchProduct

Exposing Empirical Links between COVID-19 Situation Report and Available Data: The Case of Nigeria

2020

Ever since the index case of COVID-19 was announced in Nigeria, the number of confirmed cases has gradually increased to 46,140 (about 4.5% of total confirmed cases in Africa) as the time of writing this article. This seemingly low number of confirmed cases has provoked heated debates among researchers. This cross-sectional study explores the Nigerian COVID-19 report to expose some links between the number of confirmed cases, testing, and some environmental conditions. The findings reveal that there is no state in Nigeria which has up to 12 confirmed cases per 10,000 population. That means, the number of confirmed COVID-19 cases is less than 0.15% of the population of people across each sta…

2019-20 coronavirus outbreakAfrican most populous nationCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Populationlcsh:MedicineNigeria010501 environmental sciences01 natural sciencesArticle03 medical and health sciences0302 clinical medicineenvironmental factors030212 general & internal medicineeducationIndex case0105 earth and related environmental scienceseducation.field_of_studypandemiclcsh:Rcorrelational studyCOVID-19low number of testingVDP::Matematikk og Naturvitenskap: 400::Matematikk: 410GeographyCorrelational studyDemographyDiseases
researchProduct

The Performative University: ‘Targets’, ‘Terror’ and ‘Taking Back Freedom’ in Academia

2020

The file attached to this record is the author's final peer reviewed version. The Publisher's final version can be found by following the DOI link. This special issue assembles eight papers which provide insights into the working lives of early career to more senior academics, from several different countries. The first common theme which emerges is around the predominance of ‘targets’, enacting aspects of quantification and the ideal of perfect control and fabrication. The second theme is about the ensuing precarious evocation of ‘terror’ impacting on mental well-being, albeit enacted in diverse ways. Furthermore, several papers highlight a particular type of response, beyond complicity to…

2019-20 coronavirus outbreakAlternative organizationsUniversitiesHigher educationbusiness.industryStrategy and ManagementSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Critical management studiesGeneral Decision SciencesGender studiesPerformative utteranceCritical management studiesperformativityManagement of Technology and InnovationPerformativityHigher educationSociologyEarly careerBusiness schoolsbusinessInstitute for Management ResearchTheme (narrative)Management Learning
researchProduct

Anakinra for severe forms of COVID-19

2020

2019-20 coronavirus outbreakAnakinraRheumatologyCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyImmunology and AllergyMedicinebusinessVirologyArticlemedicine.drugThe Lancet Rheumatology
researchProduct

An expression of concern on research during the Covid-19 pandemic

2020

2019-20 coronavirus outbreakBiomedical ResearchCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralScientific MisconductSettore MED/11BetacoronavirusRetraction of Publication as TopicPandemicHumansMedicinePandemicsClinical Trials as TopicbiologySARS-CoV-2business.industryCOVID-19Reproducibility of ResultsGeneral Medicinebiology.organism_classificationVirologyCoronavirus InfectionsCardiology and Cardiovascular MedicinebusinessBetacoronavirusCoronavirus Infections
researchProduct

2020

In a survey of household cats and dogs of laboratory-confirmed COVID-19 patients, we found a high seroprevalence of SARS-CoV-2 antibodies, ranging from 21% to 53%, depending on the positivity criteria chosen. Seropositivity was significantly greater among pets from COVID-19+ households compared to those with owners of unknown status. Our results highlight the potential role of pets in the spread of the epidemic.

2019-20 coronavirus outbreakCATSHigh prevalenceCoronavirus disease 2019 (COVID-19)biologybusiness.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)030231 tropical medicinePublic Health Environmental and Occupational HealthVirology3. Good health03 medical and health sciences0302 clinical medicineInfectious DiseasesOne Healthbiology.proteinMedicineSeroprevalence030212 general & internal medicineAntibodybusinessOne Health
researchProduct

Towards a European strategy to address the COVID-19 pandemic

2021

2019-20 coronavirus outbreakCOVID-19 VaccinesCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Physical DistancingMass Vaccination03 medical and health sciences0302 clinical medicinePolitical scienceCorrespondencePandemicHumans030212 general & internal medicinePandemicsHealth policy030304 developmental biology0303 health sciencesSARS-CoV-2Health PolicyIncidenceIncidence (epidemiology)COVID-19General MedicineVirology3. Good healthEuropeMass vaccinationHuman medicineThe Lancet
researchProduct